Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Goldin

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
RMD Open|November 28, 2024
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung diseaseSangmee Sharon Bae, Fereidoun Abtin, Grace Kim, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 2016
SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the LungsJered P Sieren, John D Newell, R Graham Barr, et al.
Transplantation|September 17, 2021
Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts MortalityS Samuel Weigt, Grace-Hyun J Kim, Heather D Jones, et al.
Radiology|November 4, 2010
The National Lung Screening Trial: overview and study design, Denise R Aberle, Christine D Berg, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Rheumatology (Oxford, England)|September 2, 2024
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Didem Saygin, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2017
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized TrialRichard N van Zyl-Smit, Aliasgar Esmail, Mary E Bateman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|May 9, 2007
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisPhilip J Clements, Michael D Roth, Robert Elashoff, et al.
RMD Open|November 28, 2024
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung diseaseSangmee Sharon Bae, Fereidoun Abtin, Grace Kim, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 2016
SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the LungsJered P Sieren, John D Newell, R Graham Barr, et al.
Transplantation|September 17, 2021
Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts MortalityS Samuel Weigt, Grace-Hyun J Kim, Heather D Jones, et al.
Radiology|November 4, 2010
The National Lung Screening Trial: overview and study design, Denise R Aberle, Christine D Berg, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Rheumatology (Oxford, England)|September 2, 2024
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Didem Saygin, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2017
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized TrialRichard N van Zyl-Smit, Aliasgar Esmail, Mary E Bateman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Pageof 11